Posts dated "08/2015"

New Class of Self-Injectable Cholesterol-Lowering Medication

PCSK9 interferes with the liver's ability to remove cholesterol from the blood.  Evolocumab is a human monoclonal antibody that inhibits or blocks the PCSK9 and is administered via subcutaneous injection once or twice a month depending on the dosage.

Read More